Talazoparib 25 mg | 99.82%
TargetMol
Talazoparib is a new-type PARP inhibitor (IC50: 0.58 nM), It similarly binds to PARP1/2 (Kis: 1.2/0.85 nM).
More Information Supplier PageTalazoparib
Search Results
Lapatinib Ditosylate 200 mg | 99.71%
TargetMol
Lapatinib Ditosylate (Tykerb ditosylate) is an effective EGFR and ErbB2 inhibitor (IC50: 10.8/9.2 nM for EGFR/ErbB2).
More Information Supplier PageLapatinib Ditosylate
Toltrazuril (sulfone) 100 mg | Purity Not Available
TargetMol
Toltrazuril sulfone (Ponazuril) is an antiprotozoal agent that acts upon Coccidia parasites.
More Information Supplier PageToltrazuril (sulfone)
Diflunisal 100 mg | Purity Not Available
TargetMol
Diflunisal is a cyclooxygenase (COX) Inhibitor, used as an anti-inflammatory analgesic.
More Information Supplier PageDiflunisal
Quinestrol 200 mg | 98.00%
TargetMol
Quinestrol is a synthetic estrogen, applied in hormone replacement therapy, and occasionally to use in cancer and prostate cancer treatment.
More Information Supplier PageQuinestrol
Sotrastaurin 5 mg | Purity Not Available
TargetMol
Sotrastaurin is a potent pan-PKC inhibitor (Kis: 0.95/0.64/2.1/3.2/1.8/0.22 nM for PKCα/βI/δ/ε/η/θ).
More Information Supplier PageSotrastaurin
Sotrastaurin 50 mg | Purity Not Available
TargetMol
Sotrastaurin is a potent pan-PKC inhibitor (Kis: 0.95/0.64/2.1/3.2/1.8/0.22 nM for PKCα/βI/δ/ε/η/θ).
More Information Supplier PageSotrastaurin
Sotrastaurin 25 mg | Purity Not Available
TargetMol
Sotrastaurin is a potent pan-PKC inhibitor (Kis: 0.95/0.64/2.1/3.2/1.8/0.22 nM for PKCα/βI/δ/ε/η/θ).
More Information Supplier PageSotrastaurin
Sotrastaurin 10 mg | Purity Not Available
TargetMol
Sotrastaurin is a potent pan-PKC inhibitor (Kis: 0.95/0.64/2.1/3.2/1.8/0.22 nM for PKCα/βI/δ/ε/η/θ).
More Information Supplier PageSotrastaurin
Diflunisal 500 mg | Purity Not Available
TargetMol
Diflunisal is a cyclooxygenase (COX) Inhibitor, used as an anti-inflammatory analgesic.
More Information Supplier PageDiflunisal